"How have reimbursement policies changed Poland’s pharma and healthcare markets? Market report details results, explores forecasts for development to 2015. Implementation of the provisions of Poland’s Reimbursement Act has created visible consequences in the country’s pharmaceutical and healthcare markets. The experienced analysts at PMR have kept close watch on these changes, observing events and collecting data that documents variations in sales values of various medications, the value of the hospital market and best-selling medicines across the industry. " https://www.reportscorner.com/reports/22407/Pharmaceutical-and-healthcare-market-in-Poland-2013/

1. RC
Reports Corner
Pharmaceutical and healthcare market in Poland
2013

2. DescriptionDescription
Reports Cornerwww.reportscorner.com
"How have reimbursement policies changed Poland’s pharma and
healthcare markets?Market report details results, explores
forecasts for development to 2015.Implementation of the
provisions of Poland’s Reimbursement Act has created visible
consequences in the country’s pharmaceutical and healthcare
markets. The experienced analysts at PMR have kept close watch
on these changes, observing events and collecting data that
documents variations in sales values of various medications, the
value of the hospital market and best-selling medicines across the
industry."

3. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
How have reimbursement policies changed Poland’s pharma and
healthcare markets?
Market report details results, explores forecasts for development
to 2015.
Implementation of the provisions of Poland’s Reimbursement Act
has created visible consequences in the country’s pharmaceutical
and healthcare markets. The experienced analysts at PMR have
kept close watch on these changes, observing events and
collecting data that documents variations in sales values of
various medications, the value of the hospital market and best-
selling medicines across the industry.
The result of this study is the publication of Pharmaceutical and
healthcare market in Poland 2013, Development forecasts for
2013-2015. This report analyses overall market conditions and
evaluates the changes attributed to the Reimbursement Act as
observed in pharmacy and hospital environments.

4. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
It profiles the leading pharmaceutical manufacturers and
examines products in terms of their ATC designations, revealing
the opportunities and obstacles to success in these markets and
predictions for changes in the future.
The report presents foundational data on the value of the
pharmacy and healthcare markets, emphasizing the changes that
have come to light since the Reimbursement Act was first
implemented. It covers modifications to the list made in 2012 and
2013, and analyses each of the applicable ATC categories in terms
of the effects of reimbursement policies on profitability. It
contains listings of the top selling pharmaceutical preparations as
well as dietary supplements and newly introduced generic and
innovative products.
Information about consumer preferences with regard to innovative
treatments, demographic details in relation to use of medicines
and ample epidemiological data combine to give readers a
complete overview of market activity.

5. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
Profiles of leading pharmaceutical and healthcare companies
reveal revenues and strategies for adaptation to changing
conditions that are forecast to continue during the period 2013-
2015.
Reimbursement information is provided as follows: NFZ
expenditures for open reimbursements, chemotherapy
programmes and other drugs during 2012, NFZ total 2012
expenditures for drugs according to ATC category, level of
required copayment and by voivodship. Expected changes to drug
and reimbursement lists over the forecast period are also
furnished.
This document also describes the situation in Poland’s healthcare
segment, supplying data on the total numbers of doctors and their
applicable specialties and hospitals in terms of quantity, patient
capacity, and NFZ contract status. It instructs readers on the
characteristics that distinguish medical spending as part of the
public or private healthcare sector in Poland.

6. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
Pharmaceutical and healthcare market in Poland 2013,
Development forecasts for 2013-2015 is an indispensible
information source for pharmaceutical manufacturers, healthcare
services providers and the companies that furnish their supplies,
and providers of consultancy, financial and research and analysis
services.
Users will find this report especially valuable in their efforts to
begin and expand business operations, assess potential
investment opportunities, prepare forecasts for sales and
earnings, and examine the value and business activities of
competing business interests. Government and commerce
organisations will also utilise the data and forecasts to prepare
internal and external reporting on Poland’s pharmaceutical and
healthcare sector.

7. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
I. Methodology 11
II. Executive summary 15
III. Overview of the pharmaceutical market in Poland 21
IV. Pharmacy market by therapeutic groups 37
V. Bestselling drugs 61
VI. Drug reimbursement in Poland 63
VII. Pharmaceutical companies in Poland 103
VIII. Epidemiological trends 127
IX. Consumer behaviour 149
X. Legal environment 165
XI. Healthcare market in Poland 191
XII. List of graphs 203
XIII. List of tables 209
XIV. About PMR 213

8. For more informationFor more information
Reports Cornerwww.reportscorner.com
For more information please visit our website
https://www.reportscorner.com/reports/22407/Pharmaceutical-and-healthcare-
market-in-Poland-2013/

9. Reports Corner
Thank YouThank You
www.reportscorner.com
RC
Contact us: contact@reportscorner.com

10. Reports Corner
Thank YouThank You
www.reportscorner.com
RC
Contact us: contact@reportscorner.com